-+ 0.00%
-+ 0.00%
-+ 0.00%

Omega Healthcare Investors (OHI) Stock Still Looks Below Fair Value Despite 102% Returns

Simply Wall St·08/29/2026 23:21:57
Listen to the news

Omega Healthcare Investors has more than doubled shareholders' money over the past five years, yet several valuation checks still point to the stock trading at a discount to its estimated intrinsic value. With the share price recently at US$45.99 and short term returns under pressure, investors are weighing how much of that long term gain is already reflected in today’s valuation.

  • Omega Healthcare Investors has returned 101.6% over five years. This puts the recent pullback in context as a pause after a strong multi year run.
  • The stability and timing of future rental cash flows from its healthcare properties can support the current valuation. Any pressure on tenants' finances or rent coverage remains a key risk for the cash flow outlook.
  • The stock scores highly on value checks and screens as undervalued by a Discounted Cash Flow (DCF) intrinsic value estimate. Together these factors suggest the broader checks lean cheap for a 5 out of 5 value score.

The issue now is whether Omega Healthcare Investors' current price still offers a margin of safety relative to its intrinsic value estimate after such strong longer term returns.

Capitalize on Omega Healthcare Investors' value signal and compare it with other potential opportunities that screen well on valuation and quality by reviewing the curated 44 high quality undervalued stocks.

Is Omega Healthcare Investors Still Cheap on Cash Flow?

The Discounted Cash Flow (DCF) model for Omega Healthcare Investors focuses on the cash the business can return to shareholders over time. On the latest twelve month numbers, Omega Healthcare Investors generated about US$946.2 million of free cash flow, and the model assumes these cash flows continue growing from this base rather than shrinking. Projecting those cash flows forward and discounting them back gives an estimated intrinsic value of about $89 per share.

Compared with the recent share price near $45.99, the DCF output points to the stock trading at a 48.4% discount to that intrinsic estimate. The model relies on adjusted funds from operations, which is a common approach for health care REITs where rental cash flows and reinvestment needs matter more than accounting earnings. On these assumptions, the long term cash flows implied for Omega Healthcare Investors appear higher than what the current price reflects.

Overall, the DCF workup suggests Omega Healthcare Investors stock currently looks undervalued relative to its estimated intrinsic value.

Our Discounted Cash Flow (DCF) analysis suggests Omega Healthcare Investors is undervalued by 48.4%. Track this in your watchlist or portfolio, or discover 44 more high quality undervalued stocks.

OHI Discounted Cash Flow as at Aug 2026
OHI Discounted Cash Flow as at Aug 2026

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Omega Healthcare Investors.

Is Omega Healthcare Investors Still Cheap on Earnings?

P/E is a useful cross check for Omega Healthcare Investors because investors often anchor health care REITs to their earnings power as well as to cash flow. On this measure, Omega Healthcare Investors trades at about 16.6x earnings, which is very close to the health care REITs industry average of roughly 16.6x. That suggests the stock is priced broadly in line with the sector on simple earnings.

The fair P/E ratio from the model is about 27.7x, based on the company’s size, industry profile and risk factors. Compared with the current 16.6x, this indicates the stock trades at a sizeable discount to the earnings multiple the model suggests could be justified for Omega Healthcare Investors. Against peers, where the average P/E is about 68.0x, the current valuation also appears conservative.

On the P/E multiple, Omega Healthcare Investors stock appears undervalued relative to the level implied by the fair ratio and peer group benchmarks.

NYSE:OHI P/E Ratio as at Aug 2026
NYSE:OHI P/E Ratio as at Aug 2026

See what the numbers say about this price — find out in our valuation breakdown.

The Omega Healthcare Investors Narrative: What Would Justify Today's Price?

Simply Wall St Narratives pick up where the Omega Healthcare Investors valuation work leaves off and spell out what growth, margin and earnings paths would need to hold for the stock to be worth materially more or less than today's price. Rather than relying on a single multiple or model output, each narrative lays out the assumptions behind its view of fair value so you can check those against Omega Healthcare Investors' results as they are reported.

You can add your voice to the Simply Wall St community by sharing a Narrative on Omega Healthcare Investors that sets out your number driven view on where its growth, margins and execution go from here. Put your thesis on record and see how it holds up as new results for Omega Healthcare Investors' business and stock are reported over time.

Do you think there's more to the story for Omega Healthcare Investors? Head over to our Community to see what others are saying!

The Bottom Line

Omega Healthcare Investors screens as undervalued on both its Discounted Cash Flow (DCF) intrinsic value estimate and its current P/E multiple, which broadly agree that the market is applying a conservative price to its cash flows and earnings power. The key question is whether rental cash flows from its healthcare properties remain resilient enough to justify that intrinsic value case. If tenant strength and rent coverage hold up, the current discount could represent mispricing. If those cash flows come under pressure, the apparent valuation gap may be the market correctly pricing in that risk.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.